Penny Grewal Daumerie
Overview
Explore the profile of Penny Grewal Daumerie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santos A, Brito M, Oliveira A, Davila R, Gama H, Silva E, et al.
Malar J
. 2024 Dec;
23(1):399.
PMID: 39716245
Background: To eliminate malaria by 2035, Brazil must address Plasmodium vivax. Previously, first-line treatment was chloroquine plus 7-day primaquine (PQ) without glucose-6-phosphate dehydrogenase (G6PD) deficiency testing. In 2021, point-of-care quantitative...
2.
Santos A, Brito M, Silva E, Rocha F, Oliveira A, Davila R, et al.
PLoS Negl Trop Dis
. 2024 Jun;
18(6):e0012197.
PMID: 38837977
Effective radical cure of Plasmodium vivax malaria is essential for malaria elimination in Brazil. P. vivax radical cure requires administration of a schizonticide, such as chloroquine, plus an 8-aminoquinoline. However,...
3.
Brito M, Rufatto R, Brito-Sousa J, Murta F, Sampaio V, Balieiro P, et al.
Lancet Infect Dis
. 2024 Mar;
24(6):629-638.
PMID: 38452779
Background: Prevention of Plasmodium vivax malaria recurrence is essential for malaria elimination in Brazil. We evaluated the real-world effectiveness of an updated treatment algorithm for P vivax radical cure in...
4.
Brito M, Rufatto R, Murta F, Sampaio V, Balieiro P, Baia-Silva D, et al.
Lancet Glob Health
. 2024 Feb;
12(3):e467-e477.
PMID: 38365417
Background: To achieve malaria elimination, Brazil must implement Plasmodium vivax radical cure. We aimed to investigate the operational feasibility of point-of-care, quantitative, glucose-6-phosphate dehydrogenase (G6PD) testing followed by chloroquine plus...
5.
Pradhan M, Pradhan S, Dutta A, Shah N, Valecha N, Joshi P, et al.
PLoS One
. 2022 Mar;
17(3):e0265352.
PMID: 35324920
Background: The Comprehensive Case Management Project (CCMP), was a collaborative implementation research initiative to strengthen malaria early detection and complete treatment in Odisha State, India. Methods: A two-arm quasi-experimental design...
6.
Anvikar A, Sahu P, Pradhan M, Sharma S, Ahmed N, Yadav C, et al.
Am J Trop Med Hyg
. 2022 Jan;
106(3):831-840.
PMID: 35008062
Plasmodium vivax malaria elimination requires radical cure with chloroquine/primaquine. However, primaquine causes hemolysis in glucose-6-phosphate dehydrogenase-deficient (G6PDd) individuals. Between February 2016 and July 2017 in Odisha State, India, a prospective,...
7.
Tandon R, Spark-DePass E, Sharma A, Gerth-Guyette E, Slutsker L, Grewal Daumerie P, et al.
J Vector Borne Dis
. 2021 Jul;
57(2):182-186.
PMID: 34290164
India contributes to over 40% of the global Plasmodium vivax disease burden, and P. vivax contributes to approximately one-third of all malaria in India. Government of India has set goals...
8.
Samby K, Ramachandruni H, Banerji J, Burrows J, Grewal Daumerie P, Hooft van Huijsduijnen R, et al.
J Vector Borne Dis
. 2019 May;
56(1):15-24.
PMID: 31070161
The global fight against malaria requires continual development of new tools. Collaborations in India have played a key role in MMV's partnerships to discover, develop and deliver new medicines. Over...
9.
Pradhan S, Pradhan M, Dutta A, Shah N, Joshi P, Pradhan K, et al.
PLoS One
. 2019 Jan;
14(1):e0208943.
PMID: 30601833
Background: In 2013, the Comprehensive Case Management Programme (CCMP) was initiated to assess the impact of universal access to diagnosis and treatment and improved surveillance on malaria transmission in different...
10.
Talisuna A, Grewal Daumerie P, Balyeku A, Egan T, Piot B, Coghlan R, et al.
Malar J
. 2012 Oct;
11:356.
PMID: 23107021
Background: Artemisinin-based combination therapy (ACT), the treatment of choice for uncomplicated falciparum malaria, is unaffordable and generally inaccessible in the private sector, the first port of call for most malaria...